NIH to Use 'Omics with Diverse Teams to Identify Mystery Diseases | GenomeWeb
NEW YORK (GenomeWeb News) – In an effort to discover and find the causes for a variety of undiagnosed diseases, the National Institutes of Health plans to start a new program that will bring to bear the knowledge and resources of its many institutes, including those focused on genomics and proteomics, on patients who have uncommon or unknown conditions.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.